Sign Up Today and Learn More About QurAlis Stock
Invest in or calculate the value of your shares in QurAlis or other pre-IPO companies through EquityZen's platform.
QurAlis Stock (QURL)
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
About QurAlis Stock
Founded
2016
Headquarters
Cambridge, MA, US
Industries
Travel and Tourism, Manufacturing, Space
QurAlis Press Mentions
Stay in the know about the latest news on QurAlis
ALS results to propel QurAlis’ QRL-101 into Phase II
thepharmaletter • Dec 31, 2025
QurAlis announces Phase I QRL-101 trial topline results in ALS
clinicaltrialsarena • Dec 30, 2025
QurAlis Confirms Signal of Target Engagement in ALS Patients in Phase 1 Clinical Trial of QRL-101, a Potentially Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener
businesswire • Dec 29, 2025
QurAlis Confirms Signal of Target Engagement in ALS Patients in Phase 1 Clinical Trial of QRL-101, a Potentially Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener
biospace • Dec 29, 2025
QurAlis to Present Data From its Phase 1 Clinical Trial of QRL-101, a Potential Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener, at American Epilepsy Society 2025 Annual Meeting
biospace • Dec 02, 2025
QurAlis Management
Leadership team at QurAlis
Board Observer
Anthony Walsh
Board of Directors
Cillian King
Join now and verify your accreditation status to gain access to:
- QurAlis Current Valuation
- QurAlis Stock Price
- QurAlis Management
- Available deals in QurAlis and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- QurAlis Cap Table and Funding History by Share Class and Liquidity Preferences
- QurAlis Revenue and Financials
- QurAlis Highlights
- QurAlis Business Model
- QurAlis Risk Factors
- QurAlis Research Report from SACRA Research
Trading QurAlis Stock
How to invest in QurAlis stock?
Accredited investors can buy pre-IPO stock in companies like QurAlis through EquityZen funds. These investments are made available by existing QurAlis shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell QurAlis stock?
Shareholders can sell their QurAlis stock through EquityZen's private company marketplace. EquityZen's network includes over 410K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
